Eribulin as an effective monotherapy in a chemo-pretreated woman with metastatic breast cancer: a case report

Breast Cancer

First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer

Breast.

Araki K, Fukada I, Yanagi H, Kobayashi K, Shibayama T, Horii R, Takahashi S, Akiyama F, Ohno S, Ito Y

doi: 10.1016/j.breast.2017.06.015.

Radio-Oncology

Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports

J Breast Cancer.

Byun KD, Ahn SG, Baik HJ, Lee A, Bae KB, An MS, Kim KH, Shin JH, Park HK, Cho H, Jeong J, Kim TH.

doi: 10.4048/jbc.2016.19.2.214.

Breast Cancer

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study

Breast Cancer Res Treat.

Vernieri C, Milano M, Mennitto A, Maggi C, Ferrari B, Rinaldi L, Mennitto R, Stefanetti C, Re B, Mariani G, Bianchi G, Capri G, de Braud F

doi: 10.1007/s10549-017-4336-z.

Breast Cancer

Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy

Breast.

Montagna E, Vingiani A, Maisonneuve P, Cancello G, Contaldo F, Pruneri G, Colleoni M

doi: 10.1016/j.breast.2017.05.009.

Breast CancerGastrointestinal Cancer

Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement

Oncology.

Dottorini L, Catena L, Sarno I, Di Menna G, Marte A, Bajetta E.

doi: 10.1159/000489062.

Metastatic uterine cancer looking as cervical fibroid in recurrent breast cancer woman: a case report

Obstet Gynecol Sci.

Seo SY, Shin JY, Ji YI

doi: 10.5468/ogs.2017.60.5.481.

Breast Cancer

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

N Engl J Med.

Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P

doi: 10.1056/NEJMoa1706450.

Breast CancerGastrointestinal CancerGynecologic Cancer

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

World J Surg Oncol.

Mori R, Futamura M, Morimitsu K, Saigo C, Miyazaki T, Yoshida K

doi: 10.1186/s12957-017-1185-5.

Breast Cancer

Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

JAMA Oncol.

Liu S, Chen B, Burugu S, Leung S, Gao D, Virk S, Kos Z, Parulekar WR, Shepherd L, Gelmon KA, Nielsen TO

doi: 10.1001/

Related content

First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer

Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study

Unfavorable prognostic role of tumor-infiltrating lymphocytes in hormone-receptor positive, HER2 negative metastatic breast cancer treated with metronomic chemotherapy

Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement

Metastatic uterine cancer looking as cervical fibroid in recurrent breast cancer woman: a case report

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report

Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial